Dale, C., Takhar, R., Carragher, R., Torabi, F., Katsoulis, M., Duffield, S., Kent, S., Mueller, T., Kurdi, A., McTaggart, S., Abbasizanjani, H., Hollings, S., Scourfield, A., Lyons, R., Griffiths, R., Lyons, J., Davies, G., Harris, D., Handy, A., Mizani, M., Tomlinson, C., Ashworth, M., Denaxas, S., Banerjee, A., Sterne, J., Lovibond, K., Brown, P., Bullard, I., Priedon, R., Mamas, M., Slee, A., Lorgelly, P., Pirmohamed, M., Khunti, K., Sattar, N., Morris, A., Sudlow, C., Akbari, A., Bennie, M. & Sofat, R. 2022, 'The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data'. To be published in MedRxiv [Preprint]. Available at: https://doi.org/10.1101/2021.12.31.21268587